Page last updated: 2024-09-02

fk 888 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

fk 888 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies

Compound Research Comparison

Studies
(fk 888)
Trials
(fk 888)
Recent Studies (post-2010)
(fk 888)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
97239,156187552

Protein Interaction Comparison

ProteinTaxonomyfk 888 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, PJ; Hirayama, Y; Lei, YH; Rogers, DF1
El-Shazly, AE; Eura, M; Ishikawa, T; Masuyama, K1

Other Studies

2 other study(ies) available for fk 888 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    British journal of pharmacology, 1993, Volume: 108, Issue:3

    Topics: Animals; Blood Pressure; Bronchoconstriction; Capsaicin; Dipeptides; Electric Stimulation; Evans Blue; Exudates and Transudates; Guinea Pigs; Hypotension; Indoles; Male; Neurokinin A; Peptide Fragments; Peptides, Cyclic; Platelet Activating Factor; Receptors, Neurokinin-2; Receptors, Neurotransmitter; Respiratory Mechanics; Smoking; Substance P; Vagus Nerve

1993
Immunoregulatory effect of substance P in human eosinophil migratory function.
    Immunological investigations, 1996, Volume: 25, Issue:3

    Topics: Adjuvants, Immunologic; Chemotaxis, Leukocyte; Dipeptides; Eosinophils; Humans; Hypersensitivity; In Vitro Techniques; Indoles; Inflammation; Interleukin-5; Male; Neurokinin-1 Receptor Antagonists; Platelet Activating Factor; Recombinant Proteins; Substance P

1996